NeuroTherapia, Inc. Company Profile, Contacts & Intelligence

Biotechnology Research1500 Chagrin River Rd8 employeesFounded 2015
2 contacts with email or phone data2 with email data1 with phone data
View verified contacts Compare competitors
Employees
8
Company source estimate
Reachable Contacts
2
Visible contacts with email or phone data
Contacts With Email
2
2 of 4 visible contacts

NeuroTherapia, Inc. Overview

NeuroTherpia, Inc., founded in 2015 by Drs. Mohamed Naguib and Joseph Foss, is developing new therapies for diseases with an underlying component of neuroinflammation. Initial research has led to the development of our lead compound NTRX-07. NTRX-07 (previously known as MDA7) which has been shown to decrease activation of microglial cells in the brain. Decreasing activation of these cells leads to decreased inflammation and decreased injury to surrounding nerve cells. Decreasing this inflammation can treat and even prevent the development of neuropathic pain in settings of nerve injury or chemotherapy. Recent work has shown that blocking this inflammation is also important in reversing the effects seen in Alzheimer's Disease (AD). We have completed initial Phase 1 safety trials of NTRX-07 in volunteers and are planning to do a Phase 2 trial in patients with AD in 2025. Tony Giordano, Ph.D. is the CEO for NeuroTherapia. He is a serial entrepreneur who brings his extensive research background in AD and business experience to the company. Joseph Foss, M.D., has over 30 years experience in translational clinical pharmacology, and has led successful drug development programs in academia and industry. Marianna Kiraly, Ph.D. is the VP for Research and Development. Marianna has over 15 years of experience in research, data analysis and education at academic institutions and corporations. Before joining NeuroTherapia she served as the Neuroscience Lead for Switch Therapeutics.

Headquarters
1500 Chagrin River Rd
Website
neurotherapia.com
Industry
Biotechnology Research
Founded
2015
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Phone Number
Available in AeroLeads
Company Email
Available in AeroLeads
Pharmaceutical Development Pain Alzheimer's disease biotech research

NeuroTherapia, Inc. Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

2 contacts with contact data
2 with email data and 1 with phone data in the visible sample.

NeuroTherapia, Inc. People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

L
Linda Li
Partner, Cleveland Clinic Ventures;
A
Anthony Giordano
Biotech Entrepreneur
EP
J
Joseph Foss
Founder at Neurotherapia, Inc.
E
A
Akhil Saklecha Md, Mba
Board Member, Vc, Chief Scientific

NeuroTherapia, Inc. Workforce Composition

Seniority breakdown across 4 visible profiles.

Executive
2
Individual contributor
2

Compare Similar Companies to NeuroTherapia, Inc.

Explore companies in related markets and compare their industry and employee estimates.

Company Industry / match Employee estimate Page
Outpace Bio Biotechnology Research 70 View company
Shinobi Therapeutics Biotechnology Research 37 View company
SiteOne Therapeutics, Inc. Biotechnology Research 23 View company
Serina Therapeutics, Inc. Pharmaceutical Manufacturing 20 View company
Annovis Bio, Inc. Biotechnology Research 12 View company
Nammi Therapeutics, Inc. Biotechnology Research 7 View company
Doohickey AI Software Development 5 View company
Nob Hill Therapeutics Biotechnology Research 5 View company
Algiax Pharmaceuticals Pharmaceutical Manufacturing 4 View company
Red Queen Therapeutics Biotechnology Research 3 View company